Articles with public access mandates - Heather MurrayLearn more
Available somewhere: 19
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
S Degryse, CE De Bock, S Demeyer, I Govaerts, S Bornschein, D Verbeke, ...
Leukemia 32 (3), 788-800, 2018
Mandates: Research Foundation (Flanders), European Commission
Targeting oncogenic signaling in mutant FLT3 acute myeloid leukemia: the path to least resistance
D Staudt, HC Murray, T McLachlan, F Alvaro, AK Enjeti, NM Verrills, ...
International journal of molecular sciences 19 (10), 3198, 2018
Mandates: Australian Research Council
Nucleotide excision repair deficiency in melanoma in response to UVA
HC Murray, VE Maltby, DW Smith, NA Bowden
Experimental hematology & oncology 5, 1-11, 2015
Mandates: National Health and Medical Research Council, Australia, Canadian Institutes …
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia
HC Murray, AK Enjeti, RGS Kahl, HM Flanagan, J Sillar, ...
Leukemia 35 (6), 1782-1787, 2021
Mandates: Australian Research Council, National Health and Medical Research Council …
Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease
DA Skerrett‐Byrne, EG Bromfield, HC Murray, MFB Jamaluddin, ...
Respirology 26 (10), 960-973, 2021
Mandates: National Health and Medical Research Council, Australia
Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
MD Dun, A Mannan, CJ Rigby, S Butler, HD Toop, D Beck, P Connerty, ...
Leukemia 34 (12), 3393-3397, 2020
Mandates: Australian Research Council, National Health and Medical Research Council …
Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma
NA Bowden, KA Ashton, RE Vilain, KA Avery-Kiejda, RJ Davey, ...
PLoS One 8 (8), e70424, 2013
Mandates: National Health and Medical Research Council, Australia
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
ZP Germon, JR Sillar, A Mannan, RJ Duchatel, D Staudt, HC Murray, ...
Science Signaling 16 (778), eabp9586, 2023
Mandates: National Health and Medical Research Council, Australia
Synergistic targeting of DNA-PK and KIT signaling pathways in KIT mutant acute myeloid leukemia
HC Murray, K Miller, JS Brzozowski, RGS Kahl, ND Smith, SJ Humphrey, ...
Molecular & Cellular Proteomics 22 (3), 2023
Mandates: Australian Research Council, National Health and Medical Research Council …
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
RJ Duchatel, ER Jackson, SG Parackal, D Kiltschewskij, IJ Findlay, ...
The Journal of clinical investigation 134 (6), 2024
Mandates: National Health and Medical Research Council, Australia
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
DE Staudt, HC Murray, DA Skerrett-Byrne, ND Smith, MFB Jamaluddin, ...
Clinical Proteomics 19 (1), 48, 2022
Mandates: National Health and Medical Research Council, Australia
Pharmaco‐phosphoproteomic analysis of cancer‐associated KIT mutations D816V and V560G
HC Murray, K Miller, MD Dun, NM Verrills
Proteomics 24 (9), 2300309, 2024
Mandates: National Health and Medical Research Council, Australia
Immortalized mouse caput epididymal epithelial (mECap18) cell line recapitulates the in‐vivo environment
JE Mulhall, NA Trigg, IR Bernstein, AL Anderson, HC Murray, P Sipilä, ...
Proteomics 24 (7), 2300253, 2024
Mandates: National Health and Medical Research Council, Australia
Blockade of redox second messengers inhibits JAK/STAT and MEK/ERK signaling sensitizing FLT3-mutant acute myeloid leukemia to targeted therapies
ZP Germon, JR Sillar, A Mannan, RJ Duchatel, D Staudt, HC Murray, ...
bioRxiv, 2022.03. 09.483687, 2022
Mandates: National Health and Medical Research Council, Australia
Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge
DA Skerrett‐Byrne, SJ Stanger, NA Trigg, AL Anderson, P Sipilä, ...
Andrology, 2024
Mandates: National Health and Medical Research Council, Australia
Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts
Y Chen, S Roselli, N Panicker, JS Brzozowski, DA Skerrett‐Byrne, ...
Proteomics 24 (7), 2300267, 2024
Mandates: National Health and Medical Research Council, Australia
Adaptive resistance to FLT3 inhibitors is potentiated by ROS-driven DNA repair signalling
DE Staudt, ZP Germon, A Mannan, T McLachlan, HC Murray, RJ Duchatel, ...
bioRxiv, 2024.07. 26.605229, 2024
Mandates: National Health and Medical Research Council, Australia
Upregulated cholesterol biosynthesis facilitates the survival of methylation-retaining AML cells following decitabine treatment.
DR Bond, SM Burnard, K Uddipto, KV Hunt, BM Harvey, ...
bioRxiv, 2024.01. 30.577864, 2024
Mandates: National Health and Medical Research Council, Australia
High-Throughput Global Phosphoproteomic Profiling Using Phospho Heavy-Labeled-Spiketide FAIMS Stepped-CV DDA (pHASED)
DE Staudt, HC Murray, DA Skerrett-Byrne, ND Smith, MF Jamaluddin, ...
bioRxiv, 2022.04. 22.489124, 2022
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program